To Patrick J. Mahaffy and Lawrence M. Gold:
Mr. Mahaffy, wake up! Five years sweet dreams is over. This is 1998, not another spring. Move around, look around, at other bts and tried to learn something. Pharmaceutical business is not banking or finance, this is business for grownups and hard workers, not dreamers. Probably you figured this out already. If not, you case is totally lost. Maybe another 100K shares option may motivate you, not tiny 100 shares by which you want to bay workers loyalty. Personal example is best motivation, not cheap attempt to bay people sentiment. Wake up!
Mr. Gold, you are father of SELECT technology. So, where are faster, cheaper, and better drugs from this technology? Are 10 years of *hard work* and *investors $$$$* not enough for some serious results? Not cheap hype on intraocular aptamer for ARMD. Company claim potent aptamers as grow factor inhibitors (VEGF, PDGF, bFGF,..). When will this aptamers enter clinical studies (for cancer)? By 0001 (oh no, it is 2001). No counting from beginning. Other companies are moving ahead, and NXTR is still at *winter sleep*. Does Colorado really have bad weather, so winter is over whole year?
Good luck (or dreams).
BTW, this year I vote against both of you.
Miljenko Zuanic
|
